CHMP Delays Review of Portola's Ondexxya; Who Will Pass Muster?

 
• By Maureen Kenny
  
Beneftis vs Risks
A positive benefit-risk balance is critical if a new drug is to secure approval • Source: Shutterstock

More from Europe

More from Geography